Basket cover image
13 handpicked stocks

Crypto

These carefully selected stocks represent companies at the forefront of blockchain technology and cryptocurrency innovation. Handpicked by our professional analysts, these investments offer exposure to the fast-growing digital currency market without directly buying crypto itself.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+3

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at mai 18

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

COIN

Coinbase Global Inc

COIN

Current price

$302.07

MSTR

MicroStrategy Inc.

MSTR

Current price

$336.57

PYPL

PayPal Holdings, Inc.

PYPL

Current price

$69.05

About This Group of Stocks

1

Our Expert Thinking

The cryptocurrency industry stands at the cutting edge of financial innovation. These companies are pioneering blockchain technology, crypto mining, trading platforms, and digital payment systems that are reshaping global finance. With the crypto market projected to reach $1.2 trillion by 2030, these stocks offer exposure to this explosive growth.

2

What You Need to Know

This group includes a mix of direct crypto miners, exchanges, and companies integrating blockchain into their business models. While offering high growth potential, crypto stocks can be volatile due to regulatory changes, technology shifts, and cryptocurrency price fluctuations. These investments provide a way to participate in the crypto market through established companies.

3

Why These Stocks

These companies represent leaders across different crypto sectors, from mining operations to exchanges and blockchain integration. Each was selected based on their market position, growth trajectory, and innovation in the cryptocurrency space. Rather than investing directly in digital currencies, these stocks provide exposure to the companies building and supporting the crypto ecosystem.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+130.64%

Group Performance Snapshot

130.64%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 130.64% over the next year.

9 of 10

Stocks Rated Buy by Analysts

9 of 10 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🚀

Explosive Growth Potential

The total value of digital assets has grown over 5,000% in eight years, and companies in this space are positioned to benefit from continued adoption and expansion of blockchain technology.

🔮

Future of Finance

These companies aren't just participants in a trend – they're reshaping how money works in the digital age. Getting in now means gaining exposure to technology that could fundamentally transform global commerce.

🌊

Ride the Crypto Wave Without the Deep Dive

Not ready to buy actual cryptocurrencies? These stocks give you exposure to the crypto revolution while investing in established companies with business models and balance sheets.

Why Invest with Nemo Money?

Nemo Logo Fade
🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All